Engineering Escherichia coli NfsB To Activate a Hypoxia-Resistant Analogue of the PET Probe EF5 To Enable Non-Invasive Imaging during Enzyme Prodrug Therapy-Reference-Cited by-同舟云学术

Engineering Escherichia coli NfsB To Activate a Hypoxia-Resistant Analogue of the PET Probe EF5 To Enable Non-Invasive Imaging during Enzyme Prodrug Therapy

Published:2019-08-12 Issue:35 Volume:58 Page:3700-3710
ISSN:0006-2960
Container-title:Biochemistry
language:en
Short-container-title:Biochemistry

Author:

Williams Elsie M.¹,Rich Michelle H.¹,Mowday Alexandra M.²,Ashoorzadeh Amir²,Copp Janine N.¹,Guise Christopher P.²³,Anderson Robert F.²³,Flanagan Jack U.²³,Smaill Jeff B.²³,Patterson Adam V.²³,Ackerley David F.¹³^ORCID

Affiliation:

1. School of Biological Sciences, Victoria University of Wellington, Wellington 6012, New Zealand

2. Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Auckland 1023, New Zealand

3. Maurice Wilkins Centre for Molecular Biodiscovery, Auckland 1023, New Zealand

Funder

Cancer Society of New Zealand

Health Research Council of New Zealand

Royal Society of New Zealand

Genesis Oncology Trust

Publisher

American Chemical Society (ACS)

Subject